# Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer

> **NCT04542603** · PHASE1 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** [11C]PiB and 18F-labeled DPA-714 PET scan

## Key facts

- **NCT ID:** NCT04542603
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-06
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No recruitment/enrollment and funding expired.
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04542603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04542603, "Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04542603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*